Diagnosis: Acanthosis Nigricans
The most likely diagnosis is acanthosis nigricans (AN), a condition characterized by hyperpigmented, velvety thickening of the skin in flexural areas, and the primary treatment involves addressing underlying metabolic causes, particularly insulin resistance, with metformin 500-850 mg twice daily if metabolic syndrome or prediabetes is present, along with topical retinoids (tretinoin 0.05% cream nightly) for cosmetic improvement.
Clinical Reasoning
The presentation of longstanding black pigmentation in the groin, inner thighs, and pelvic folds since childhood that has recently darkened, without inflammatory symptoms (no itching, rash, or burning), is pathognomonic for acanthosis nigricans. The key diagnostic features are:
- Bilateral, symmetric distribution in intertriginous areas (groin, thighs, pelvic folds)
- Velvety, hyperkeratotic texture with hyperpigmentation
- Asymptomatic (no pruritus or burning)
- Gradual onset and progression since childhood with recent darkening
The recent darkening at age 29 suggests progression, often associated with worsening insulin resistance, weight gain, or hormonal changes.
Differential Diagnoses to Exclude
While the provided evidence discusses various hyperkeratotic conditions, none match this clinical picture:
- Lichen sclerosus 1: Causes white, atrophic patches with architectural changes and is symptomatic (itching, pain)
- Pigmented Bowen disease 2: Presents as solitary plaques, not bilateral symmetric involvement
- Granular parakeratosis 3: Causes erythema and desquamation, not smooth hyperpigmentation
- Porokeratosis variants 4, 5: Have characteristic raised borders with central atrophy, not velvety texture
Treatment Algorithm
1. Identify and Address Underlying Causes (Priority)
Screen for metabolic disorders:
- Fasting glucose and HbA1c (insulin resistance/diabetes)
- Lipid panel
- Thyroid function tests
- Consider PCOS evaluation in women (testosterone, LH/FSH ratio)
If insulin resistance/prediabetes is present:
- Metformin 500 mg twice daily, titrate to 850-1000 mg twice daily over 2-4 weeks
- Weight loss through diet and exercise (5-10% body weight reduction can significantly improve AN)
2. Topical Treatments for Cosmetic Improvement
First-line topical therapy:
- Tretinoin 0.05% cream applied nightly to affected areas
- Start with every other night for 2 weeks to assess tolerance, then advance to nightly
- May cause initial irritation; use emollients as needed
Alternative/adjunctive topical options:
- Ammonium lactate 12% cream twice daily (keratolytic and moisturizing)
- Topical vitamin D analogs (calcipotriol) may help reduce hyperkeratosis
- Combination therapy: Tretinoin at night + ammonium lactate in morning
3. Avoid Inappropriate Treatments
Do not use:
- High-potency topical corticosteroids long-term in flexural areas (can worsen skin atrophy and pigmentation) 6
- Bleaching agents alone (address underlying cause first)
Important Caveats
- Biopsy is not routinely needed for typical bilateral symmetric AN in flexural areas, but consider if presentation is atypical, unilateral, or rapidly progressive (to exclude malignancy-associated AN or other diagnoses)
- Malignancy-associated AN is rare but presents with rapid onset in older adults, often with mucosal involvement—this patient's childhood onset makes this unlikely
- Cosmetic improvement takes 3-6 months of consistent treatment; set realistic expectations
- Recurrence is common if underlying metabolic issues are not addressed
Follow-up Strategy
- 3-month follow-up to assess metabolic parameters and treatment response
- 6-month follow-up to evaluate cosmetic improvement and reinforce lifestyle modifications
- Long-term management focuses on maintaining metabolic control rather than repeated dermatologic visits
The absence of inflammatory symptoms and the bilateral symmetric distribution in a young woman with longstanding disease makes acanthosis nigricans the clear diagnosis, with treatment prioritizing metabolic health over purely cosmetic interventions.